Your browser doesn't support javascript.
loading
The effectiveness and acceptability of the Bergen 4-day treatment for adolescents with OCD: a replication and extension.
Skjold, Solvei Harila; Hagen, Kristen; Wheaton, Michael G; Hjelle, Kay Morten; Björgvinsson, Thröstur; Hansen, Bjarne.
Afiliação
  • Skjold SH; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
  • Hagen K; Center for Crisis Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.
  • Wheaton MG; OCD-team, Haukeland University Hospital, Bergen, Norway.
  • Hjelle KM; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway. kristen.hagen@helse-mr.no.
  • Björgvinsson T; Møre and Romsdal Hospital Trust, Hospital of Molde, Molde, Norway. kristen.hagen@helse-mr.no.
  • Hansen B; Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway. kristen.hagen@helse-mr.no.
BMC Psychiatry ; 24(1): 148, 2024 Feb 21.
Article em En | MEDLINE | ID: mdl-38383351
ABSTRACT

BACKGROUND:

B4DT is a concentrated treatment format with prolonged sessions of exposure and ritual prevention (ERP) delivered over four consecutive days. Two previous open trials demonstrated promising results of the Bergen 4-day treatment (B4DT) for adolescents with obsessive-compulsive disorder (OCD). The aim of the current study was to replicate the initial results with a new sample of adolescents and different therapists at different sites across Norway.

METHODS:

Forty-three youths participated in treatment program. At pretreatment, posttreatment, and the three-month follow-up, OCD symptoms were assessed using the CY-BOCS interview, while the GAD-7 and PHQ-9 were administered to rate general anxiety symptoms and depressive symptoms. Acceptability and patient satisfaction with the treatment were rated with the CSQ-8.

RESULTS:

All symptoms were significantly reduced at posttreatment and follow-up. At posttreatment, 36 patients (85.71%) were defined as responders, while 29 patients (69.05%) achieved remission. At the three-month follow-up, 36 patients (92.3%) were defined as responders, while 33 patients (84.62%) were in remission. CSQ-8 scores indicated that the patients were highly satisfied with the treatment.

CONCLUSIONS:

The B4DT was successfully replicated in a new sample at different sites across Norway, which indicates that this treatment is generalizable, effective and acceptable to adolescents with OCD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Transtorno Obsessivo-Compulsivo Limite: Adolescent / Humans País/Região como assunto: Europa Idioma: En Revista: BMC Psychiatry Assunto da revista: PSIQUIATRIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Transtorno Obsessivo-Compulsivo Limite: Adolescent / Humans País/Região como assunto: Europa Idioma: En Revista: BMC Psychiatry Assunto da revista: PSIQUIATRIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Noruega